News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
339,733 Results
Type
Article (20557)
Company Profile (134)
Press Release (319030)
Multimedia
Podcasts (92)
Webinars (16)
Section
Business (105662)
Career Advice (886)
Deals (18587)
Drug Delivery (100)
Drug Development (50926)
Employer Resources (79)
FDA (7768)
Job Trends (7793)
News (186443)
Policy (17428)
Tag
Academia (736)
Accelerated approval (10)
Adcomms (21)
Allergies (61)
Alliances (27967)
ALS (71)
Alzheimer's disease (715)
Antibody-drug conjugate (ADC) (126)
Approvals (7826)
Artificial intelligence (207)
Autoimmune disease (30)
Automation (8)
Bankruptcy (178)
Best Places to Work (5553)
BIOSECURE Act (13)
Biosimilars (122)
Biotechnology (58)
Bladder cancer (56)
Brain cancer (26)
Breast cancer (167)
Cancer (1611)
Cardiovascular disease (175)
Career advice (725)
Career pathing (21)
CAR-T (72)
CDC (9)
Cell therapy (193)
Cervical cancer (8)
Clinical research (43597)
Collaboration (690)
Compensation (273)
Complete response letters (35)
COVID-19 (1129)
CRISPR (40)
C-suite (310)
Cystic fibrosis (73)
Data (1952)
Decentralized trials (2)
Denatured (23)
Depression (50)
Diabetes (190)
Diagnostics (1844)
Digital health (10)
Diversity (7)
Diversity, equity & inclusion (22)
Drug discovery (114)
Drug pricing (149)
Drug shortages (33)
Duchenne muscular dystrophy (102)
Earnings (40158)
Editorial (35)
Employer branding (10)
Employer resources (75)
Events (49717)
Executive appointments (575)
FDA (8851)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (2)
Funding (463)
Gene editing (71)
Generative AI (19)
Gene therapy (200)
GLP-1 (709)
Government (1949)
Grass and pollen (4)
Guidances (175)
Healthcare (5915)
HIV (21)
Huntington's disease (16)
IgA nephropathy (36)
Immunology and inflammation (131)
Immuno-oncology (11)
Indications (31)
Infectious disease (1226)
Inflammatory bowel disease (99)
Inflation Reduction Act (10)
Influenza (30)
Intellectual property (91)
Interviews (117)
IPO (7409)
IRA (52)
Job creations (2440)
Job search strategy (650)
Kidney cancer (8)
Labor market (45)
Layoffs (320)
Leadership (21)
Legal (4140)
Liver cancer (34)
Longevity (6)
Lung cancer (254)
Lymphoma (144)
Machine learning (10)
Management (30)
Manufacturing (346)
MASH (73)
Medical device (1984)
Medtech (1987)
Mergers & acquisitions (11557)
Metabolic disorders (663)
Multiple sclerosis (70)
NASH (20)
Neurodegenerative disease (83)
Neuropsychiatric disorders (32)
Neuroscience (1196)
NextGen: Class of 2025 (2360)
Non-profit (912)
Now hiring (35)
Obesity (400)
Opinion (211)
Ovarian cancer (47)
Pain (108)
Pancreatic cancer (65)
Parkinson's disease (106)
Partnered (12)
Patents (213)
Patient recruitment (120)
Peanut (19)
People (33984)
Pharmaceutical (74)
Pharmacy benefit managers (25)
Phase I (13676)
Phase II (18416)
Phase III (14799)
Pipeline (1407)
Policy (193)
Postmarket research (1619)
Preclinical (4803)
Press Release (29)
Prostate cancer (96)
Psychedelics (21)
Radiopharmaceuticals (169)
Rare diseases (339)
Real estate (3189)
Recruiting (30)
Regulatory (13035)
Reports (25)
Research institute (823)
Resumes & cover letters (139)
Rett syndrome (3)
RNA editing (8)
RSV (32)
Schizophrenia (85)
Series A (81)
Series B (54)
Service/supplier (7)
Sickle cell disease (46)
Special edition (19)
Spinal muscular atrophy (112)
Sponsored (15)
Startups (2027)
State (2)
Stomach cancer (10)
Supply chain (65)
Tariffs (77)
The Weekly (67)
Vaccines (347)
Venture capital (44)
Weight loss (289)
Women's health (19)
Worklife (8)
Date
Today (36)
Last 7 days (242)
Last 30 days (1034)
Last 365 days (15815)
2025 (10990)
2024 (17669)
2023 (19637)
2022 (25866)
2021 (26639)
2020 (24870)
2019 (20057)
2018 (15587)
2017 (17253)
2016 (16202)
2015 (18801)
2014 (14787)
2013 (12552)
2012 (13482)
2011 (13817)
2010 (12738)
Location
Africa (412)
Alabama (32)
Alaska (1)
Arizona (77)
Arkansas (8)
Asia (25379)
Australia (3271)
California (3629)
Canada (1482)
China (522)
Colorado (140)
Connecticut (142)
Delaware (121)
Europe (52455)
Florida (644)
Georgia (80)
Hawaii (1)
Idaho (17)
Illinois (346)
India (31)
Indiana (223)
Iowa (3)
Japan (193)
Kansas (73)
Kentucky (24)
Louisiana (3)
Maine (4)
Maryland (487)
Massachusetts (3017)
Michigan (56)
Minnesota (191)
Mississippi (3)
Missouri (33)
Montana (10)
Nebraska (11)
Nevada (30)
New Hampshire (8)
New Jersey (1449)
New Mexico (21)
New York (1032)
North Carolina (634)
North Dakota (2)
Northern California (1572)
Ohio (101)
Oklahoma (7)
Oregon (21)
Pennsylvania (834)
Puerto Rico (15)
Rhode Island (22)
South America (610)
South Carolina (6)
Southern California (1526)
Tennessee (48)
Texas (497)
United States (14170)
Utah (78)
Virginia (135)
Washington D.C. (55)
Washington State (290)
West Virginia (1)
Wisconsin (33)
339,733 Results for "fennec pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025
August 12, 2025
·
2 min read
Press Releases
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
August 14, 2025
·
17 min read
Business
Fennec Pharmaceuticals Announces Management Change
Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.
July 1, 2024
·
4 min read
Press Releases
Fennec Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025
May 9, 2025
·
1 min read
Press Releases
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
May 13, 2025
·
14 min read
Press Releases
Fennec Pharmaceuticals Announces Commercial Launch of PEDMARQSI® In Germany
February 7, 2025
·
10 min read
Press Releases
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2024 Financial Results on March 10, 2025
March 7, 2025
·
1 min read
Press Releases
Fennec Pharmaceuticals Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
March 10, 2025
·
17 min read
C-suite
With Political Disarray at an All-Time High, the Pharma CEO Chair Is a Lonely Gig
As the political winds shift on a whim and public distrust of the pharma industry reaches fever pitch over drug pricing, executives are being asked to navigate an impassible path.
August 27, 2025
·
7 min read
·
Annalee Armstrong
Press Releases
Medicus Pharma Ltd. Completes Acquisition of Antev Limited
Antev is developing Teverelix, a next generation GnRH Antagonist, as a first in class market product for Acute Urinary Retention (AURr) and high CV risk Prostate Cancer collecting representing ~US$6 billion in potential market opportunityPatrick J. Mahaffy, a veteran pharma executive and the former Chairman of Antev, appointed to Medicus Board of Directors
September 2, 2025
·
10 min read
1 of 33,974
Next
